Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?

References

• Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med 1995;155(11):1125-8
   PubMedGoogle Scholar
• Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002;34(8):1098-107
   PubMed Web of Science ®Google Scholar
• Sepkowitz KA. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis? Mayo Clin Proc 1996;71(1):102-3
   Google Scholar
• Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987;316(26):1627-32
   PubMed Web of Science ®Google Scholar
• Rubin E, Zak F. Pneumocystis carinii pneumonia in the adult. N Engl J Med 1960;262:1315-17
   Google Scholar
• Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977;297(26):1419-26
   PubMed Web of Science ®Google Scholar
• Hardy AM, Wajszczuk CP, Suffredini AF, et al. Pneumocystis cariniipneumonia in renal transplant patients treated with cyclosporine and steroids. J Infect Dis 1984;149:143-7
   PubMed Web of Science ®Google Scholar
• Hofflin JM, Potasman I, Baldwin JC, et al. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987;106:209-16
   PubMed Web of Science ®Google Scholar
• Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten year’s experience. Rev Infect Dis 1982;4:1119-32
   PubMedGoogle Scholar
• Dummer JS, Montero CG, Griffith BP, et al. Infections in heart-lung transplants. Transplantation 1986;41:725-9
   PubMed Web of Science ®Google Scholar
• Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence if Pneumocystis carinii infection after lung-heart transplantation: implications for lung defense and allograft survival. Am Rev Respir Dis 1988;137:1268-74
   Google Scholar
• LaClair RA. Transplantation pneumonia associated with Pneumocystis carinii among recipients of cardiac transplants. Am Rev Respir Dis 1969;100:874-5
   Google Scholar
• Narins B, Jessup M. Pneumocystis carinii pneumonia after heart transplantation: a growing problem. J Heart Transplant 1990;9:67; Abstract 51
   Google Scholar
• Olsen SO, Renlund DG, O’Connell JB, et al. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim-sulfamethaxazole. Transplantation 1993;56:359-62
   PubMed Web of Science ®Google Scholar
• Stringer J, Beard C, Miller R, Wakefield A. A new name for Pneumocystis from humans and new perspectives on the host-pathogen relationship. Emerg Infect Dis 2002;8(9):891-6
   PubMed Web of Science ®Google Scholar
• Frenkel JK. Pneumocystis pneumonia, an immunodeficiency-dependent disease (IDD): a critical historical overview. J Eukaryot Microbiol 1999;46:89S-92S
   PubMed Web of Science ®Google Scholar
• Sepkowitz KA, Brown AE, Telzak EE, et al. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992;267(6):832-7
   PubMed Web of Science ®Google Scholar
• Graham BS. Opportunistic infections in endogenous Cushing’s syndrome. Ann Intern Med 1984;101(3):334-8
   Google Scholar
• Berney S. Characterization of glucocorticosteroid-induced changes in lymphocyte circulation in the rat. Clin Res 1974;22:141A
   Google Scholar
• Moorhead JW, Claman HN. Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow. Cell Immunol 1972;5:74
   Google Scholar
• Fauci AS, Dale DC. The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood 1975;46:235
   PubMed Web of Science ®Google Scholar
• Brahim F. Marrow lymphocyte production during chronic hydrocortisone administration. J Reticuloendothel Soc 1978;23:111
   Google Scholar
• Slade JD, Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med 1983;101(3):479-87
   Google Scholar
• Walzer PD, Powell RDJr, Yoneda K, et al. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun 1980;27(3):928-37
   Google Scholar
• Farr RW. Pneumocystis carinii pneumonia due to corticosteroids. South Med J 1992;85(1):52-3
   Google Scholar
• Huynh-Do U, Gantenbein H, Binswanger U. Pneumocystis carinii pneumonia during immunosuppressive therapy for antineutrophil cytoplasmic autoantibody-positive vasculitis. Arch Intern Med 1995;155(8):872-4
   Google Scholar
• Frenkel JK, Good JT, Shultz JA. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest 1966;15(10):1559-77
   Google Scholar
• Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 2007;82(9):1052-9
   PubMed Web of Science ®Google Scholar
• Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996;71(1):5-13
   PubMed Web of Science ®Google Scholar
• Ognibene FP, Shelhamer JH, Hoffman GS, et al. Pneumocystis cariniipneumonia: a major complication of immunosuppressive therapy in patients with Wegener’s granulomatosis. Am J Respir Crit Care Med 1995;151:795-9
   PubMed Web of Science ®Google Scholar
• Sepkowitz KA. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 1993;17(Suppl 2):S416-22; Review
   Google Scholar
• Saito K, Nakayamada S, Nakano K, et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue dieases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology (Oxford) 2004;43(4):479-85
   PubMed Web of Science ®Google Scholar
• Slivka A. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 1993;94(2):216-19
   Google Scholar
• Kozeny GA, Quinn JP, Bansal VK, et al. Pneumocystis carinii pneumonia: a lethal complication of “pulse” methylprednisolone therapy. Int J Artif Organs 1987;10(5):304-6
   Google Scholar
• Wing EJ, Bruns FJ, Fraley DS, et al. Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 1980;244:2423-6
   PubMed Web of Science ®Google Scholar
• Vidal S, de la Horra C, Martin J, et al. Pneumocystis jirovecii colonization in patients with interstitial lung disease. Clin Microbiol Infect 2006;12(3):231-5
   Google Scholar
• Vassallo R, Standing JE, Limper AH. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 2000;164:3755-63
   PubMed Web of Science ®Google Scholar
• Prevost MC, Escamilla R, Aliouat EM, et al. Pneumocystosis pathophysiology. FEMS Immunol Med Microbiol 1998;22:123-8
   PubMedGoogle Scholar
• Limper AH, Offord KP, Smith TF, et al. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140(5):1204-9
   PubMedGoogle Scholar
• Bozzette SA. The use of corticosteroids in Pneumocystis carinii pneumonia. J Infect Dis 1990;162(6):1365-9
   Google Scholar
• Bozzette SA, Sattler FR, Chiu J, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 1990;323(21):1451-7
   PubMed Web of Science ®Google Scholar
• Schnipper S, Small CB, Lehach J, et al. Pneumocystis carinii pneumonia presenting as asthma: increased bronchial hyperresponsiveness in Pneumocystis carinii pneumonia. Ann Allergy 1993;70(2):141-6
   Google Scholar
• Thomas CFJr, Limper AH. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without aquired immune deficiency syndrome. Semin Respir Infect 1998;13(4):289-95; Review
   PubMedGoogle Scholar
• Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100(5):663-71
   PubMed Web of Science ®Google Scholar
• Monnet X, Vidal-Petiot E, Osman D, et al. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care 2008;12(1):R28
   PubMed Web of Science ®Google Scholar
• Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000;118:704-11
   PubMed Web of Science ®Google Scholar
• Mikaelsson L, Jacobsson G, Andersson R. Pneumocystis pneumonia – a retrospective study 1991–2001 in Gothenburg, Sweden. J Infect 2006;53:260-5
   PubMedGoogle Scholar
• Ewig S, Bauer T, Schneider C, et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressedpatients. Eur Respir J 1995;8:1548-53
   PubMed Web of Science ®Google Scholar
• Asai N, Motojima S, Ohkuni Y, et al. Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection. J Infect Chemother 2012;18:898-905
   Google Scholar
• Nevez G, Raccurt C, Jounieaux V, et al. Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients. AIDS 1999;13(4):535
   Google Scholar
• De Boer M, Bruijnesteijn van Coppenraet L, Gaasbeek A, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis 2007;44(9):1143-9
   PubMed Web of Science ®Google Scholar
• Rabodonirina M, Vanhems P, Couray-Targe S, et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with hiv-infected patients. Emerg Infect Dis 2004;10(10):1766-73
   Google Scholar
• Chave JP, David S, Wauters JP, et al. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS 1991;5(8):927-32
   Google Scholar
• Vargas SL, Ponce CA, Gigliotti F, et al. Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol 2000;38(4):1536-8
   Google Scholar
• Gutiérrez S, Respaldiza N, Campano E, et al. Pneumocystis jirovecii colonization in chronic pulmonary disease. Parasite 2011;18(2):121-6
   Google Scholar
• Shimizu Y, Sunaga N, Dobashi K, et al. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infect Dis 2009;9:47
   Google Scholar
• Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006;27(1):143-50
   Google Scholar
• Varela JM, Respaldiza N, Sanchez B, et al. Lymphocyte response in subjects with chronic pulmonary disease colonized with Pneumocystis jirovecii. J Eukaryot Microbiol 2003;50(Suppl):672-3
   Google Scholar
• Gutiérrez S, Respaldiza N, Campano E, et al. Pneumocystis jirovecii colonization in chronic pulmonary disease. Parasite 2011;18:121-6
   PubMedGoogle Scholar
• Zalacain R, Sobradillo V, Amilibia J, et al. Redisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999;13(2):343-8
   PubMed Web of Science ®Google Scholar
• Monsó E, Rosell A, Bonet G, et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 1999;13(2):338-42
   Google Scholar
• Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57(9):759-64
   PubMed Web of Science ®Google Scholar
• Murphy T. The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin Infect Dis 2008;47(12):1534-6
   Google Scholar
• Garcés Jarque JM, Terradas Robledo R, Alvarez-Lerma F, et al. Lung aspergillosis. Role of the corticoids as associated risk factor in the patient with chronic bronchitis. Rev Clin Esp 2003;203(10):472-4
   Google Scholar
• Johnson D. Chronic candidal bronchitis: a consecutive series. Open Respir Med J 2012;6:145-9
   PubMedGoogle Scholar
• Nseir S, Jozefowicz E, Cavestri B. Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary restrospective case-control study. Intensive Care Med 2007;33(1):137-42
   Google Scholar
• Jiva T, Jacoby H, Weymouth L, et al. Mycobacterium xenopi: innocent Bystander or Emerging Pathogen? Clin Infect Dis 1997;24(2):225-32
   Google Scholar
• Morris A, Sciurba FC, Norris KA. Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease? COPD 2008;5(1):43-51
   PubMedGoogle Scholar
• Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev 2012;25(2):297-317
   PubMed Web of Science ®Google Scholar
• Morris A, Sciurba FC, Lebedeva IP, et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004;170(4):408-13
   PubMed Web of Science ®Google Scholar
• Fleury J, Escudier E, Pocholle MJ, et al. Cell population obtained by bronchoalveolar lavage in Pneumocystis carinii pneumonitis. Acta Cytol 1985;29:721-6
   Google Scholar
• Baughman RP, Dohn MN, Frame PT. Generalized immune response toPneumocystis carinii infection in the lung. J Protozool 1991;38:187S-8S
   Google Scholar
• Jensen BN, Lisse IM, Gerstoft J, et al. Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis. AIDS 1991;5:527-33
   PubMed Web of Science ®Google Scholar
• Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 2008;197(1):10-17
   PubMed Web of Science ®Google Scholar
• Calderon EJ, Rivero L, Respaldiza N, et al. Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci. Clin Infect Dis 2007;45:e17-19
   PubMed Web of Science ®Google Scholar
• Maskell NA, Waine DJ, Lindley A, et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax 2003;58(7):594-7
   PubMed Web of Science ®Google Scholar
• CDC. Recommendations for prophylaxis against P. carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm Rep 1992;41(RR-4):1-11
   Google Scholar
• Fauci AS, Macher AM, Longo DL, et al. NIH Conference: acquire Immunodeficiency Syndrome; Epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984;100:92-106
   PubMed Web of Science ®Google Scholar
• Hughes WT, Price RA, Kim HK, et al. Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 1973;82:404-15
   PubMed Web of Science ®Google Scholar
• Hughes WT, Feldman S, Aur RJA, et al. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 1975;36:2004-9
   PubMed Web of Science ®Google Scholar
• Siegel SE, Nesbit ME, Baehner R, et al. Pneumonia during therapy for childhood acute lymphoblastic leukemia. Am J Dis Child 1980;134:28-34
   PubMedGoogle Scholar
• Cyklis R, Zielinska A. Pneumocystis cariniiinfection in children with acute leukemia and non-Hodgkin malignant lymphoma. Pediatr Pol 1983;58:337-40
   Google Scholar
• De Castro N, Neuville S, Sarfati C, et al. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant 2005;36:879-83
   PubMed Web of Science ®Google Scholar
• Schürmann M, Schürmann D, Schindler R, et al. Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients. Transpl Immunol 2013;28(4):159-63
   Google Scholar
• Overgaard UM, Helweg-Larsen J. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004. Scand J Infect Dis 2007;39(6-7):589-95
   PubMed Web of Science ®Google Scholar
• Mansharamani NG, Balachandran D, Vernovsky I, et al. Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000;118(3):712-20
   PubMed Web of Science ®Google Scholar
• Nevez G, Raccurt C, Vincent P, et al. Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts. Clin Infect Dis 1999;29(5):1331-2
   Google Scholar
• Sinicco A, Maiello A, Raiteri R, et al. Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia. Thorax 1996;51:446-7
   Google Scholar
• Gluck T, Geerdes-Fenge HF, Staub RH, et al. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection 2000;28:227-30
   PubMed Web of Science ®Google Scholar
• Lams BE, Sousa AR, Rees PJ, et al. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(5 Pt 1):1518-23
   Google Scholar
• Cruciani M, Marcati P, Malena M, et al. Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients. Eur Respir J 2002;20:982-9
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Shindo Y, Iinuma Y, et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis 2011;11:76
   PubMed Web of Science ®Google Scholar
• Azoulay É, Bergeron A, Chevret S, et al. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2009;135:655-61
   PubMed Web of Science ®Google Scholar
• Mühlethaler K, Bögli-Stuber K, Wasmer S, et al. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J 2012;39:971-8
   PubMed Web of Science ®Google Scholar
• Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of serum 1,3-ß-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 2012;50(1):7-15
   PubMed Web of Science ®Google Scholar
• Karageorgopoulous DE, Qu JM, Korbila IP, et al. Accuracy of ß-D-glucan for the diagnosis of Pneumocystic jirovecii pneumonia: a meta-analysis. Clin Microbiol Infect 2013;19:39-49
   Google Scholar